JP2021080188A - External composition for skin, deodorant agent and roll-on product - Google Patents
External composition for skin, deodorant agent and roll-on product Download PDFInfo
- Publication number
- JP2021080188A JP2021080188A JP2019207618A JP2019207618A JP2021080188A JP 2021080188 A JP2021080188 A JP 2021080188A JP 2019207618 A JP2019207618 A JP 2019207618A JP 2019207618 A JP2019207618 A JP 2019207618A JP 2021080188 A JP2021080188 A JP 2021080188A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- mass
- composition
- deodorant
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 68
- 239000002781 deodorant agent Substances 0.000 title claims abstract description 59
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 65
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 32
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims abstract description 9
- ZNVKGUVDRSSWHV-UHFFFAOYSA-L zinc;4-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=C(S([O-])(=O)=O)C=C1.OC1=CC=C(S([O-])(=O)=O)C=C1 ZNVKGUVDRSSWHV-UHFFFAOYSA-L 0.000 claims abstract description 5
- -1 fatty acid ester Chemical class 0.000 claims description 22
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 15
- 239000000194 fatty acid Substances 0.000 claims description 15
- 229930195729 fatty acid Natural products 0.000 claims description 15
- 230000000844 anti-bacterial effect Effects 0.000 claims description 14
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 claims description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 7
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 5
- 229910052751 metal Inorganic materials 0.000 claims description 5
- 239000002184 metal Substances 0.000 claims description 5
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 4
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 claims description 4
- 229960003720 enoxolone Drugs 0.000 claims description 4
- 229940094952 green tea extract Drugs 0.000 claims description 4
- 235000020688 green tea extract Nutrition 0.000 claims description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 3
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 claims description 3
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 claims description 3
- 241000196324 Embryophyta Species 0.000 claims description 3
- 102000016943 Muramidase Human genes 0.000 claims description 3
- 108010014251 Muramidase Proteins 0.000 claims description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 3
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 3
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 claims description 3
- 229910021536 Zeolite Inorganic materials 0.000 claims description 3
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 claims description 3
- 229960000686 benzalkonium chloride Drugs 0.000 claims description 3
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 claims description 3
- 229960001950 benzethonium chloride Drugs 0.000 claims description 3
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims description 3
- 229960003333 chlorhexidine gluconate Drugs 0.000 claims description 3
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 claims description 3
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 claims description 3
- 239000002734 clay mineral Substances 0.000 claims description 3
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical group O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims description 3
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 3
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 3
- 229940007062 eucalyptus extract Drugs 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 239000003205 fragrance Substances 0.000 claims description 3
- ZFSXZJXLKAJIGS-UHFFFAOYSA-N halocarban Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(NC(=O)NC=2C=CC(Cl)=CC=2)=C1 ZFSXZJXLKAJIGS-UHFFFAOYSA-N 0.000 claims description 3
- 229950006625 halocarban Drugs 0.000 claims description 3
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 claims description 3
- 229960004068 hexachlorophene Drugs 0.000 claims description 3
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 claims description 3
- 239000004325 lysozyme Substances 0.000 claims description 3
- 235000010335 lysozyme Nutrition 0.000 claims description 3
- 229960000274 lysozyme Drugs 0.000 claims description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 3
- 229960003742 phenol Drugs 0.000 claims description 3
- 229960005323 phenoxyethanol Drugs 0.000 claims description 3
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 claims description 3
- 229960001755 resorcinol Drugs 0.000 claims description 3
- 229940092258 rosemary extract Drugs 0.000 claims description 3
- 235000020748 rosemary extract Nutrition 0.000 claims description 3
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 claims description 3
- 229960004889 salicylic acid Drugs 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 235000010199 sorbic acid Nutrition 0.000 claims description 3
- 239000004334 sorbic acid Substances 0.000 claims description 3
- 229940075582 sorbic acid Drugs 0.000 claims description 3
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 claims description 3
- 229960001325 triclocarban Drugs 0.000 claims description 3
- 229960003500 triclosan Drugs 0.000 claims description 3
- 239000001069 triethyl citrate Substances 0.000 claims description 3
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 claims description 3
- 235000013769 triethyl citrate Nutrition 0.000 claims description 3
- 239000010457 zeolite Substances 0.000 claims description 3
- IOHPVZBSOKLVMN-UHFFFAOYSA-N 2-(2-phenylethyl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1CCC1=CC=CC=C1 IOHPVZBSOKLVMN-UHFFFAOYSA-N 0.000 claims description 2
- OOOOFOPLSIWRAR-NTEUORMPSA-N 3,7,11-Trimethyl-6E,10-dodecadien-1-ol Chemical compound OCCC(C)CC\C=C(/C)CCC=C(C)C OOOOFOPLSIWRAR-NTEUORMPSA-N 0.000 claims description 2
- 241000286209 Phasianidae Species 0.000 claims description 2
- 229910044991 metal oxide Inorganic materials 0.000 claims description 2
- 150000004706 metal oxides Chemical class 0.000 claims description 2
- 239000002689 soil Substances 0.000 claims description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical group [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims 2
- 229910052709 silver Inorganic materials 0.000 claims 2
- 239000004332 silver Substances 0.000 claims 2
- 230000035900 sweating Effects 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 238000002156 mixing Methods 0.000 description 11
- 239000002537 cosmetic Substances 0.000 description 10
- 230000001166 anti-perspirative effect Effects 0.000 description 9
- 239000003213 antiperspirant Substances 0.000 description 9
- 238000001035 drying Methods 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 239000003921 oil Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 208000008454 Hyperhidrosis Diseases 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 239000002649 leather substitute Substances 0.000 description 4
- 229920002545 silicone oil Polymers 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 3
- 238000005452 bending Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 230000002688 persistence Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 208000013460 sweaty Diseases 0.000 description 3
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- 208000035985 Body Odor Diseases 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 206010040904 Skin odour abnormal Diseases 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- 229940090934 diphenylsiloxy phenyl trimethicone Drugs 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 210000004709 eyebrow Anatomy 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000003595 mist Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical class OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- HDYRYUINDGQKMC-UHFFFAOYSA-M acetyloxyaluminum;dihydrate Chemical compound O.O.CC(=O)O[Al] HDYRYUINDGQKMC-UHFFFAOYSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 229940009827 aluminum acetate Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 229940048820 edetates Drugs 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 229940057874 phenyl trimethicone Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、皮膚外用組成物、デオドラント剤及びロールオン製品に関する。 The present invention relates to external skin compositions, deodorants and roll-on products.
従来、制汗剤や化粧品等に用いる皮膚外用組成物はエタノールが主要な成分として含まれる、いわゆるエタノールベースの皮膚外用組成物が多く用いられている。 Conventionally, so-called ethanol-based external composition for skin, which contains ethanol as a main component, is often used as the external composition for skin used for antiperspirants and cosmetics.
エタノールベースの皮膚外用組成物は、速乾性を有し、使用後に清涼感が残る、いわゆる使用感に優れている。また、エタノールベースに加えてシリコーン油を含む皮膚外用組成物は、更に耐水性に優れるため、特に速乾性や耐水性が必要とされる制汗剤や体臭抑制剤に適している。 The ethanol-based external composition for skin has a quick-drying property and is excellent in so-called usability, in which a refreshing feeling remains after use. In addition, the external composition for skin containing silicone oil in addition to the ethanol base is more excellent in water resistance, and is therefore particularly suitable for antiperspirants and body odor suppressants that require quick-drying and water resistance.
エタノール及びシリコーン油を含む皮膚外用組成物として、例えば、特許文献１には、（Ａ）制汗成分と、（Ｂ）側鎖両末端型ポリエーテル変性シリコーンと、（Ｃ）エタノール及び水から選択される少なくともいずれかと、（Ｄ）噴射剤とを含有することを特徴とする制汗デオドラント剤組成物が開示されている。 As a composition for external use on the skin containing ethanol and silicone oil, for example, Patent Document 1 selects from (A) antiperspirant component, (B) side chain double-ended polyether-modified silicone, and (C) ethanol and water. Disclosed is an antiperspirant deodorant composition comprising (D) a propellant and at least one of the above.
また、特許文献２には、（Ａ）制汗成分と、（Ｂ）アニオン性ポリマーと、（Ｃ）エチレンオキシド（ＥＯ）の平均付加モル数が５モル以上であるノニオン性界面活性剤と、（Ｄ）エタノールと、を含有してなり、（Ａ）成分及び（Ｂ）成分の含有量に対する（Ｃ）成分の含有量の質量比［Ｃ／（Ａ＋Ｂ）］が、０．０３〜０．７であることを特徴とする制汗剤組成物が開示されている。 Further, Patent Document 2 describes (A) an antiperspirant component, (B) an anionic polymer, and (C) a nonionic surfactant having an average addition molar number of 5 mol or more of ethylene oxide (EO). D) Ethanol is contained, and the mass ratio [C / (A + B)] of the content of the component (C) to the content of the component (A) and the component (B) is 0.03 to 0.7. The antiperspirant composition is disclosed.
しかしながら、エタノール、シリコーン油及びデオドラント成分を含む皮膚外用組成物は、塗布した後に乾燥すると固い膜が形成されるため、可動の多い脇等に塗布した場合、よれが発生し、制汗剤や体臭抑制剤としての効果が低下するおそれがあった。また、発汗の多い部位に塗布した場合、膜と皮膚の間に汗が流れ込み、よれが発生しやすくなるという問題もあった。 However, the external composition for skin containing ethanol, silicone oil and deodorant component forms a hard film when it is dried after application, so when it is applied to the side with a lot of movement, it causes kinks, and it causes antiperspirant and body odor. There was a risk that the effect as an inhibitor would be reduced. In addition, when applied to a site where sweating is frequent, there is also a problem that sweat flows between the film and the skin, and kinks are likely to occur.
したがって、本発明は、上記の課題に鑑みてなされたものであり、可動又は発汗の多い体の部位に塗布しても、よれに強く、フレキシブルな皮膜を形成することができる皮膚外用組成物、デオドラント剤及びロールオン製品を提供することを目的とする。 Therefore, the present invention has been made in view of the above problems, and is a composition for external use on the skin, which can form a flexible film that is resistant to twisting even when applied to a movable or sweaty body part. It is an object of the present invention to provide a deodorant agent and a roll-on product.
本発明の発明者は、この課題に鑑み、鋭意研究を行った。その結果、デオドラント成分に加え、エタノールと、フェニル変性シリコーンとを組み合わせて皮膚外用組成物に配合することにより、得られた皮膚外用組成物がよれに強く、フレキシブルな皮膜を形成することができることを見出し、本発明を完成するに至った。 In view of this problem, the inventor of the present invention has conducted diligent research. As a result, by blending ethanol and phenyl-modified silicone in addition to the deodorant component into the external composition for skin, the obtained external composition for skin is resistant to twisting and can form a flexible film. The heading has led to the completion of the present invention.
本発明は、以下の構成によって把握される。
（１）本発明の第１の態様は、皮膚外用組成物であって、（Ａ）デオドラント成分と、（Ｂ）エタノールと、（Ｃ）フェニル変性シリコーンとを含有することを特徴とする。
（２）本発明の第２の態様は、上記（Ａ）デオドラント成分が、（Ａ−１）アルミニウム塩及び／又はパラフェノールスルホン酸亜鉛を含むことを特徴とする(１)に記載の皮膚外用組成物である。
（３）本発明の第３の態様は、上記（Ａ）デオドラント成分が、（Ａ−２）グリチルレチン酸、イソプロピルメチルフェノール、塩化ベンザルコニウム、塩化ベンゼトニウム、ハロカルバン、塩化アルキルトリメチルアンモニウム、レゾルシン、塩酸クロルヘキシジン、フェノール、フェノキシエタノール、安息香酸誘導体、トリクロロヒドロキシジフェニルエーテル、トリクロロカルバニリド、トリエチルシトレート、ヘキサクロロフェン、グルコン酸クロルヘキシジン、トリクロサン、サリチル酸、ソルビン酸、塩化リゾチーム及びエチルヘキシルグリセリンから選ばれる殺菌成分と（Ａ−３）銀担持ゼオライト、銀担持シリカ、緑茶エキス、クワエキス、ユーカリエキス、ローズマリーエキス等の植物由来成分、ジヒドロファルネソール、フェネチルアルコール等の抗菌性香料、上記アルミニウム塩を除く金属塩、金属酸化物、珪藻土、粘土鉱物及び活性炭から選ばれる消臭成分のうち、上記（Ａ−２）及び上記（Ａ−３）から選ばれる１種又は２種以上を含むことを特徴とする(１)又は（２)に記載の皮膚外用組成物である。
（４）本発明の第４の態様は、さらに、（Ｄ）脂肪酸エステルを含有し、上記（Ｃ）フェニル変性シリコーン単独又は上記（Ｃ）フェニル変性シリコーンと上記（Ｄ）脂肪酸エステルの合計が０．１質量％以上１３．０質量％以下含まれることを特徴とする（１）〜（３）のいずれか１つに記載の皮膚外用組成物である。
（５）本発明の第５の態様は、上記（Ａ）デオドラント成分の含有量（質量％）と、上記（Ｂ）エタノールの含有量（質量％）との質量比（（Ａ）：（Ｂ））が１：９５００以上１０：１以下であることを特徴とする（１）〜（４）のいずれか１つに記載の皮膚外用組成物である。
（６）本発明の第６の態様は、上記（Ａ）デオドラント成分の含有量（質量％）と、上記（Ｃ）フェニル変性シリコーンの含有量（質量％）との質量比（（Ａ）：（Ｃ））が１：１００以上２００：１以下であることを特徴とする（１）〜（５）のいずれか１つに記載の皮膚外用組成物である。
（７）本発明の第７の態様は、上記（Ｃ）フェニル変性シリコーンの２５℃における動粘度が５ｍｍ２／ｓ以上５０００ｍｍ２／ｓ以下であることを特徴とする（１）〜（６）のいずれか１つに記載の皮膚外用組成物である。
（８）本発明の第８の態様は、（１）〜（７）のいずれか１つに記載の皮膚外用組成物を含むことを特徴とするデオドラント剤である。
（９）本発明の第９の態様は、（８）に記載のデオドラント剤を含むことを特徴とするロールオン製品である。
The present invention is grasped by the following configuration.
(1) The first aspect of the present invention is a composition for external use on the skin, which is characterized by containing (A) a deodorant component, (B) ethanol, and (C) phenyl-modified silicone.
(2) The second aspect of the present invention is the external application to the skin according to (1), wherein the (A) deodorant component contains (A-1) an aluminum salt and / or zinc paraphenol sulfonate. It is a composition.
(3) In the third aspect of the present invention, the (A) deodorant component is (A-2) glycyrrhetinic acid, isopropylmethylphenol, benzalkonium chloride, benzethonium chloride, halocarban, alkyltrimethylammonium chloride, resorcin, and the like. With bactericidal components selected from chlorhexidine hydrochloride, phenol, phenoxyethanol, benzoic acid derivatives, trichlorohydroxydiphenyl ether, trichlorocarbanilide, triethylcitrate, hexachlorophene, chlorhexidine gluconate, triclosan, salicylic acid, sorbic acid, lysozyme chloride and ethylhexyl glycerin ( A-3) Plant-derived components such as silver-supported zeolite, silver-supported silica, green tea extract, mulberry extract, eucalyptus extract, and rosemary extract, antibacterial fragrances such as dihydrofarnesol and phenethyl alcohol, metal salts other than the above aluminum salts, and metal oxidation. Among the deodorant components selected from substances, diatomaceous soil, clay minerals and activated charcoal, one or more selected from the above (A-2) and the above (A-3) is contained (1) or. The composition for external use on the skin according to (2).
(4) A fourth aspect of the present invention further contains (D) fatty acid ester, and the total of the above (C) phenyl-modified silicone alone or the above (C) phenyl-modified silicone and the above (D) fatty acid ester is 0. The composition for external use on the skin according to any one of (1) to (3), which comprises 1% by mass or more and 13.0% by mass or less.
(5) A fifth aspect of the present invention is a mass ratio ((A): (B)) of the content (mass%) of the (A) deodorant component and the content (mass%) of (B) ethanol. )) Is 1: 9500 or more and 10: 1 or less, according to any one of (1) to (4).
(6) A sixth aspect of the present invention is a mass ratio ((A):) of the content (mass%) of the (A) deodorant component and the content (mass%) of the (C) phenyl-modified silicone. The composition for external use on the skin according to any one of (1) to (5), wherein (C)) is 1: 100 or more and 200: 1 or less.
(7) A seventh aspect of the present invention is characterized in that the kinematic viscosity of the above (C) phenyl-modified silicone at 25 ° C. is 5 mm 2 / s or more and 5000 mm 2 / s or less (1) to (6). The composition for external use on the skin according to any one of the above.
(8) An eighth aspect of the present invention is a deodorant agent comprising the composition for external use on the skin according to any one of (1) to (7).
(9) A ninth aspect of the present invention is a roll-on product comprising the deodorant agent according to (8).
本発明によれば、可動又は発汗の多い体の部位に塗布しても、よれに強く、フレキシブルな皮膜を形成することができる皮膚外用組成物、デオドラント剤及びロールオン製品を提供することができる。 According to the present invention, it is possible to provide an external composition for skin, a deodorant agent and a roll-on product that can form a flexible film that is resistant to twisting even when applied to a movable or sweaty body part.
以下、本発明について詳細に説明するが、これらは例示の目的で掲げたものであって、これらにより本発明を限定するものではない。 Hereinafter, the present invention will be described in detail, but these are listed for the purpose of exemplification, and the present invention is not limited thereto.
本発明の皮膚外用組成物は、（Ａ）デオドラント成分と、（Ｂ）エタノールと、（Ｃ）フェニル変性シリコーンとを含有する。 The external composition for skin of the present invention contains (A) a deodorant component, (B) ethanol, and (C) phenyl-modified silicone.
（（Ａ）デオドラント成分）
本発明に用いられる（Ａ）デオドラント成分は、一般に、化粧料、医薬品分野で用いられ得るものであって、抗菌作用、殺菌作用、制汗作用を発揮する任意の成分をいう。デオドラント成分としては、通常化粧品や医薬品で用いられる抗菌成分、殺菌成分、制汗成分であれば特に限定されないが、中でも（Ａ−１）アルミニウム塩及び／又はパラフェノールスルホン酸亜鉛を含むことが好ましい。
アルミニウム塩としては、特に限定されないが、例えば、塩化アルミニウム、硫酸アルミニウムカリウム、硫酸アルミニウム、酢酸アルミニウム、クロルヒドロキシアルミニウム、アラントインクロルヒドロキシアルミニウム等が挙げられる。その中でも、クロルヒドロキシアルミニウムが特に好ましい。
((A) Deodorant component)
The (A) deodorant component used in the present invention generally refers to any component that can be used in the fields of cosmetics and pharmaceuticals and exerts an antibacterial action, a bactericidal action, and an antiperspirant action. The deodorant component is not particularly limited as long as it is an antibacterial component, a bactericidal component, and an antiperspirant component usually used in cosmetics and pharmaceuticals, but it is preferable to contain (A-1) aluminum salt and / or zinc paraphenol sulfonate. ..
The aluminum salt is not particularly limited, and examples thereof include aluminum chloride, potassium aluminum sulfate, aluminum sulfate, aluminum acetate, chlorohydroxyaluminum, and allantoinchlorohydroxyaluminum. Among them, chlorohydroxyaluminum is particularly preferable.
また、本発明に用いられる（Ａ）デオドラント成分としては、上記（Ａ−１）アルミニウム塩及び／又はパラフェノールスルホン酸亜鉛の他に、（Ａ−２）グリチルレチン酸、イソプロピルメチルフェノール、塩化ベンザルコニウム、塩化ベンゼトニウム、ハロカルバン、塩化アルキルトリメチルアンモニウム、レゾルシン、塩酸クロルヘキシジン、フェノール、フェノキシエタノール、安息香酸誘導体、トリクロロヒドロキシジフェニルエーテル、トリクロロカルバニリド、トリエチルシトレート、ヘキサクロロフェン、グルコン酸クロルヘキシジン、トリクロサン、サリチル酸、ソルビン酸、塩化リゾチーム及びエチルヘキシルグリセリンから選ばれる殺菌成分や、（Ａ−３）銀担持ゼオライト、銀担持シリカ、緑茶エキス、クワエキス、ユーカリエキス、ローズマリーエキス等の植物由来成分、ジヒドロファルネソール、フェネチルアルコール等の抗菌性香料、上記アルミニウム塩を除く金属塩、金属酸化物、珪藻土、粘土鉱物及び活性炭から選ばれる消臭成分等が挙げられる。
（Ａ−２）の殺菌成分及び（Ａ−３）の消臭成分は、上記（Ａ−２）及び上記（Ａ−３）から選ばれる１種又は２種以上を含むことが好ましいが、中でも（Ａ−２）はグリチルレチン酸を含むことが好ましく、（Ａ−３）は緑茶エキスを含むことが好ましい。
In addition to the above (A-1) aluminum salt and / or zinc paraphenol sulfonate, the (A) deodorant component used in the present invention includes (A-2) glycyrrhetinic acid, isopropylmethylphenol, and benzalkonium chloride. Nium, benzethonium chloride, halocarban, alkyltrimethylammonium chloride, resorcin, chlorhexidine hydrochloride, phenol, phenoxyethanol, benzoic acid derivative, trichlorohydroxydiphenyl ether, trichlorocarbanilide, triethylcitrate, hexachlorophene, chlorhexidine gluconate, triclosan, salicylic acid, Bactericidal components selected from sorbic acid, lysozyme chloride and ethylhexyl glycerin, plant-derived components such as (A-3) silver-supported zeolite, silver-supported silica, green tea extract, quail extract, eucalyptus extract, rosemary extract, dihydrophenolol, phenethyl alcohol Examples thereof include antibacterial fragrances such as, metal salts other than the above aluminum salt, metal oxides, diatomaceous earth, clay minerals, deodorant components selected from activated carbon and the like.
The bactericidal component of (A-2) and the deodorant component of (A-3) preferably contain one or more selected from the above (A-2) and (A-3), among others. (A-2) preferably contains glycyrrhetinic acid, and (A-3) preferably contains a green tea extract.
（Ａ）デオドラント成分の配合量は、本発明の皮膚外用組成物全体に対して、０．０１質量％以上５０．０質量％以下とすることが好ましく、０．０２質量％以上２０．０質量％以下とすることがより好ましい。０．０１質量％未満であると、皮膚外用組成物において十分な殺菌効果や防臭効果が得られず、一方、５０．０質量％を超えると、製剤中での均一な溶解が困難となる。
また、（Ａ）デオドラント成分中に（Ａ−２）の殺菌成分及び（Ａ−３）の消臭成分が含まれる場合、皮膚外用組成物全体に対して、（Ａ−２）の殺菌成分は０．０１質量％以上１０．０質量％以下とすることが好ましく、０．１質量％以上５．０質量％以下とすることがより好ましい。また、同様に（Ａ−３）の消臭成分は０．１質量％以上３０．０質量％以下とすることが好ましく、１．０質量％以上２０．０質量％以下とすることがより好ましい。
The blending amount of the (A) deodorant component is preferably 0.01% by mass or more and 50.0% by mass or less, and 0.02% by mass or more and 20.0% by mass with respect to the entire skin external composition of the present invention. More preferably, it is% or less. If it is less than 0.01% by mass, a sufficient bactericidal effect and deodorant effect cannot be obtained in the external composition for skin, while if it exceeds 50.0% by mass, uniform dissolution in the preparation becomes difficult.
When the (A) deodorant component contains the bactericidal component of (A-2) and the deodorant component of (A-3), the bactericidal component of (A-2) is added to the entire external composition for skin. It is preferably 0.01% by mass or more and 10.0% by mass or less, and more preferably 0.1% by mass or more and 5.0% by mass or less. Similarly, the deodorant component of (A-3) is preferably 0.1% by mass or more and 30.0% by mass or less, and more preferably 1.0% by mass or more and 20.0% by mass or less. ..
（（Ｂ）エタノール）
本発明に用いられる（Ｂ）エタノールは、皮膚外用組成物に加えることにより、速乾性及び使用感の向上につながる。
((B) Ethanol)
When the ethanol (B) used in the present invention is added to the external composition for skin, it leads to quick-drying and improvement in usability.
（Ｂ）エタノールの配合量は、本発明の皮膚外用組成物全体に対して、質量％５．０以上９５．０質量％以下とすることが好ましく、２０．０質量％以上９０．０質量％以下とすることがより好ましい。５．０質量％未満であると、本発明の皮膚外用組成物が十分な速乾性、製剤中のデオドラント成分の溶解性、及び使用感を得られず、一方、９５．０質量％を超えると、皮膚に使用した際の刺激が問題となる。 (B) The blending amount of ethanol is preferably 5.0% by mass or more and 95.0% by mass or less, and 20.0% by mass or more and 90.0% by mass or less, based on the entire external composition for skin of the present invention. The following is more preferable. If it is less than 5.0% by mass, the external composition for skin of the present invention does not have sufficient quick-drying property, solubility of the deodorant component in the preparation, and a feeling of use, while it exceeds 95.0% by mass. , Irritation when used on the skin becomes a problem.
また、本発明の皮膚外用組成物において、（Ａ）デオドラント成分の含有量（質量％）と、（Ｂ）エタノールの含有量（質量％）との質量比（（Ａ）：（Ｂ））は、１：９５００以上１０：１以下が好ましく、１：５００以上１：３以下がより好ましい。 Further, in the external composition for skin of the present invention, the mass ratio ((A): (B)) of (A) the content (mass%) of the deodorant component and (B) the content (mass%) of ethanol is , 1: 9500 or more and 10: 1 or less, more preferably 1: 500 or more and 1: 3 or less.
（（Ｃ）フェニル変性シリコーン）
本発明の皮膚外用組成物は、さらに、（Ｃ）フェニル変性シリコーンを含有する。通常の化粧品や医薬品に用いるシリコーン油では、皮膚に塗布した後のよれに弱いが、フェニル変性シリコーンを用いることにより、得られる皮膚外用組成物はよれに強く、フレキシブルな皮膜を形成することができる。
((C) Phenyl-modified silicone)
The external composition for skin of the present invention further contains (C) phenyl-modified silicone. Silicone oils used in ordinary cosmetics and pharmaceuticals are vulnerable to kinks after being applied to the skin, but by using phenyl-modified silicone, the resulting external composition for skin is vulnerable to kinks and can form a flexible film. ..
本発明に用いることができるフェニル変性シリコーンとしては、例えば、フェニルトリメチコン、ジフェニルシロキシフェニルトリメチコン、ジフェニルジメチコン、トリメチルシロキシフェニルジメチコン、トリメチルペンタフェニルトリシロキシサン、メチルフェニルポリシロキサン等が挙げられるが、中でもジフェニルシロキシフェニルトリメチコンが好ましい。 Examples of the phenyl-modified silicone that can be used in the present invention include phenyltrimethicone, diphenylsiloxyphenyltrimethicone, diphenyldimethicone, trimethylsiloxyphenyldimethicone, trimethylpentaphenyltrisiloxysan, methylphenylpolysiloxane, and the like. Of these, diphenylsiloxyphenyltrimethicone is preferable.
（Ｃ）フェニル変性シリコーンの配合量は、本発明の皮膚外用組成物全体に対して、０．１質量％以上５．０質量％以下とすることが好ましく、０．２質量％以上３．０質量％以下とすることがより好ましい。０．１質量％未満であると、本発明の皮膚外用組成物がよれに対する十分な強度を得られず、また、ざらついた不快な使用感となり、一方、５．０質量％を超えると、皮膚に使用した際のべたつきが問題となる。 The blending amount of the phenyl-modified silicone (C) is preferably 0.1% by mass or more and 5.0% by mass or less, and 0.2% by mass or more and 3.0, based on the entire skin external composition of the present invention. It is more preferably mass% or less. If it is less than 0.1% by mass, the external composition for skin of the present invention cannot obtain sufficient strength against kinks and gives a rough and unpleasant feeling of use. On the other hand, if it exceeds 5.0% by mass, the skin Stickiness when used for is a problem.
本発明の皮膚外用組成物において、（Ｃ）フェニル変性シリコーンの２５℃における動粘度は、５ｍｍ２／ｓ以上５０００ｍｍ２／ｓ以下であることが好ましく、１０ｍｍ２／ｓ以上２００ｍｍ２／ｓ以下であることがより好ましい。５ｍｍ２／ｓ未満であると、本発明の皮膚外用組成物がよれに対する十分な強度を得られず、一方、５０００ｍｍ２／ｓを超えると、皮膚に使用した際のべたつきが問題となる。 In the external composition for skin of the present invention, the kinematic viscosity of (C) phenyl-modified silicone at 25 ° C. is preferably 5 mm 2 / s or more and 5000 mm 2 / s or less, and 10 mm 2 / s or more and 200 mm 2 / s or less. More preferably. If it is less than 5 mm 2 / s, the external composition for skin of the present invention cannot obtain sufficient strength against kinks, while if it exceeds 5000 mm 2 / s, stickiness when used on the skin becomes a problem.
また、本発明の皮膚外用組成物において、（Ａ）デオドラント成分の含有量（質量％）と、（Ｃ）フェニル変性シリコーンの含有量（質量％）との質量比（（Ａ）：（Ｃ））は、１：１００以上２００：１以下が好ましく、５：１以上４０：１以下がより好ましい。 Further, in the external composition for skin of the present invention, the mass ratio ((A): (C)) of the content (mass%) of the (A) deodorant component and the content (mass%) of the (C) phenyl-modified silicone. ) Is preferably 1: 100 or more and 200: 1 or less, and more preferably 5: 1 or more and 40: 1 or less.
（（Ｄ）脂肪酸エステル）
本発明の皮膚外用組成物には、さらに（Ｄ）脂肪酸エステルを配合することが好ましい。（Ｄ）脂肪酸エステルは皮膚外用組成物を塗布し乾燥した後の肌に滑らかさを与える。
((D) fatty acid ester)
It is preferable to further add (D) fatty acid ester to the external composition for skin of the present invention. (D) The fatty acid ester gives the skin smoothness after the composition for external use on the skin is applied and dried.
（Ｄ）脂肪酸エステルとしては、例えば、炭素数６から２２の脂肪酸と炭素数１から２２の多価アルコールとのエステルから選ばれる１種以上を皮膚外用組成物に含有させることができる。 As the fatty acid ester (D), for example, one or more selected from an ester of a fatty acid having 6 to 22 carbon atoms and a polyhydric alcohol having 1 to 22 carbon atoms can be contained in the external composition for skin.
これらの中でも、（Ｄ）脂肪酸エステルは、滑らかさの観点から、炭素数８から１８の脂肪酸と炭素数３から１８のアルコール類とのエステルが好ましく、グリセリンモノカプリル酸エステル、グリセリンモノカプリン酸エステル、グリセリンモノラウリン酸エステル、プロピレングリコールモノカプリン酸エステル、ジグリセリンモノラウリン酸エステル、ミリスチン酸イソプロピル（ＩＰＭ）、パルミチン酸イソプロピル、イソノナン酸イソノニル、パルミチン酸エチルヘキシル、トリ（カプリル酸／カプリン酸）グリセリルがより好ましい。 Among these, the (D) fatty acid ester is preferably an ester of a fatty acid having 8 to 18 carbon atoms and an alcohol having 3 to 18 carbon atoms from the viewpoint of smoothness, and is a glycerin monocaprylic acid ester or a glycerin monocaprylic acid ester. , Glycerin monolauric acid ester, propylene glycol monocapric acid ester, diglycerin monolauric acid ester, isopropyl myristate (IPM), isopropyl palmitate, isononyl isononanoate, ethylhexyl palmitate, tri (caprylic acid / capric acid) glyceryl are more preferable. ..
（Ｄ）脂肪酸エステルの配合量は、本発明の皮膚外用組成物全体に対して、０．０１質量％以上８．０質量％以下とすることが好ましく、０．０５質量％以上５．０質量％以下とすることがより好ましい。０．０１質量％未満であると、十分な滑らかさが得られず、一方、８．０質量％を超えると、べたつきが問題となる。
また、（Ｃ）フェニル変性シリコーン単独又は（Ｃ）フェニル変性シリコーンと（Ｄ）脂肪酸エステルの合計が０．１質量％以上１３．０質量％以下含まれることが好ましく、０．２質量％以上８．０質量％以下含まれることがより好ましい。
The blending amount of the fatty acid ester (D) is preferably 0.01% by mass or more and 8.0% by mass or less, and 0.05% by mass or more and 5.0% by mass, based on the entire skin external composition of the present invention. More preferably, it is% or less. If it is less than 0.01% by mass, sufficient smoothness cannot be obtained, while if it exceeds 8.0% by mass, stickiness becomes a problem.
Further, it is preferable that (C) phenyl-modified silicone alone or (C) phenyl-modified silicone and (D) fatty acid ester are contained in an amount of 0.1% by mass or more and 13.0% by mass or less, and 0.2% by mass or more and 8). More preferably, it is contained in an amount of 0.0% by mass or less.
（その他の有効成分）
本発明の皮膚外用組成物には、デオドラント以外に、本発明の効果を阻害しない範囲で、保湿成分、賦活化成分、抗炎症成分、抗アレルギー成分、美白成分、ビタミン類、ＤＮＡの損傷の予防及び／又は修復作用を有する成分、収斂成分、紫外線防御成分、活性酸素抑制成分等の、化粧品や医薬部外品に添加しうる有効成分を配合することができる。これらは、１種単独又は２種以上の混合物として用いることができる。
(Other active ingredients)
In addition to deodorant, the external composition for skin of the present invention prevents damage to moisturizing ingredients, activating ingredients, anti-inflammatory ingredients, anti-allergic ingredients, whitening ingredients, vitamins, and DNA as long as the effects of the present invention are not impaired. And / or an active ingredient that can be added to cosmetics and non-pharmaceutical products, such as a component having a repairing action, a converging component, an ultraviolet protective component, and an active oxygen suppressing component, can be blended. These can be used alone or as a mixture of two or more.
（その他の成分）
皮膚外用組成物には、上記の成分以外に、本発明の効果を阻害しない範囲で、グリセリン、ジグリセリン、ジプロピレングリコール、ブチレングリコール等の炭素数４以上の多価アルコール；セチルアルコール、ステアリルアルコール、ベヘニルアルコール等の高級アルコール；カラギーナン、カルボキシビニルポリマー、ヒドロキシエチルセルロース等の増粘剤；トコフェロール及びその誘導体、アスコルビン酸及びその誘導体等の酸化防止剤；エデト酸塩、リン酸、ポリリン酸ナトリウム等の金属イオン封鎖剤；動物及び植物エキス；クエン酸、酒石酸等のｐＨ調整剤；揮発性シリコーン等のシリコーン類；界面活性剤（アニオン性、カチオン性、非イオン性、両性）、防腐剤、着色剤、香料等を適宜配合することができる。
(Other ingredients)
In addition to the above components, the composition for external use on the skin includes polyhydric alcohols having 4 or more carbon atoms such as glycerin, diglycerin, dipropylene glycol, butylene glycol; citric alcohol, stearyl alcohol, etc., as long as the effects of the present invention are not impaired. , Higher alcohols such as behenyl alcohols; thickeners such as carrageenan, carboxyvinyl polymers, hydroxyethyl cellulose; antioxidants such as tocopherols and derivatives thereof, ascorbic acid and derivatives thereof; metals such as edetates, phosphoric acid and sodium polyphosphate. Sequestrants; animal and plant extracts; pH regulators such as citric acid and ascorbic acid; silicones such as volatile silicones; surfactants (anionic, cationic, nonionic, amphoteric), preservatives, colorants, Perfume and the like can be appropriately blended.
本発明の皮膚外用組成物は、常法に従って製造することができ、例えば、Ｗ／Ｏ型、Ｏ／Ｗ型、Ｏ／Ｗ／Ｏ型、Ｗ／Ｏ／Ｗ型、Ｗ／Ｓｉ型等の乳化型、パウダー分散の非水系型、固形型、液状型、スティック型、揮発性油型、粉状型、ゼリー型、ジェル型、ペースト型、乳化高分子型、シート型、ミスト型、スプレー型等の種々の剤型とすることができる。 The external composition for skin of the present invention can be produced according to a conventional method, and for example, W / O type, O / W type, O / W / O type, W / O / W type, W / Si type and the like. Emulsified type, powder-dispersed non-aqueous type, solid type, liquid type, stick type, volatile oil type, powder type, jelly type, gel type, paste type, emulsified polymer type, sheet type, mist type, spray type It can be in various dosage forms such as.
また、本発明の皮膚外用組成物の用途は、特に限定はなく、例えば、化粧水、乳液、クリーム、ジェル、美容液、日焼け止め用化粧料、パック、マスク、ハンドクリーム、ボディローション、ボディークリーム、エッセンス等の基礎化粧料；洗顔料、メイク落とし、ひげそり剤、ボディーシャンプー等の洗浄用化粧料；リップクリーム、口紅等の口唇用化粧料、白粉・打粉、ファンデーション、マスカラ、頬紅、アイライナー、アイシャドー、眉墨、アイブロー等のメイクアップ化粧料；シャンプー、リンス、トリートメント等の毛髪用化粧料；デオドラント剤等が挙げられる。 The use of the external composition for skin of the present invention is not particularly limited, and for example, a lotion, a milky lotion, a cream, a gel, a beauty liquid, a sunscreen cosmetic, a pack, a mask, a hand cream, a body lotion, and a body cream. , Essence and other basic cosmetics; Washing pigments, makeup removers, shaving agents, body shampoo and other cleaning cosmetics; Lip cream, lipstick and other lip cosmetics, white powder / dusting powder, foundation, mascara, cheek red, eyeliner, Makeup cosmetics such as eye shadow, eyebrow, and eyebrow; hair cosmetics such as shampoo, rinse, and treatment; deodorant agents and the like.
これらの中でも、本発明の皮膚外用組成物は、優れたデオドラント効果を有することから、デオドラント剤に配合することが好ましい。デオドラント剤としては、エアゾール型、ミスト型、ロールオン型、スティック型、クリーム型等の様々な剤型とすることができるが、本発明の皮膚外用組成物を肌に高密着に塗布でき、デオドラント効果を発揮できる点から、中でもロールオン製品として利用することが好ましい。本発明の皮膚外用組成物を配合したデオドラント剤は、常法に従って製造することができる。 Among these, the external composition for skin of the present invention preferably has an excellent deodorant effect, and therefore is preferably blended with a deodorant agent. As the deodorant agent, various dosage forms such as aerosol type, mist type, roll-on type, stick type and cream type can be used, but the external composition for skin of the present invention can be applied to the skin with high adhesion, and the deodorant effect can be obtained. It is preferable to use it as a roll-on product because it can exhibit the above. The deodorant agent containing the external composition for skin of the present invention can be produced according to a conventional method.
ロールオン製品の場合、（Ａ）デオドラント成分と、（Ｂ）エタノールと、（Ｃ）フェニル変性シリコーンを含む原液の他に、原液に配合した有効成分を均一に肌に付着させるために、希釈剤として水を含むことが好ましい。本発明の皮膚外用組成物の含有量（質量％）と、水の含有量（質量％）との質量比（皮膚外用組成物：水）は、２０：８０以上９９：１以下が好ましく、３０：７０以上９７：３以下がより好ましい。 In the case of roll-on products, in addition to the undiluted solution containing (A) deodorant component, (B) ethanol, and (C) phenyl-modified silicone, as a diluent to uniformly adhere the active ingredient blended in the undiluted solution to the skin. It preferably contains water. The mass ratio (skin external composition: water) of the content (mass%) of the external composition for skin of the present invention to the content (% by mass) of water is preferably 20:80 or more and 99: 1 or less, preferably 30. : 70 or more and 97: 3 or less is more preferable.
以下の実施例により本発明を更に具体的に説明する。なお、本発明はその要旨を超えない限り、以下の実施例の記載に限定されるものではない。 The present invention will be described in more detail with reference to the following examples. The present invention is not limited to the description of the following examples as long as the gist of the present invention is not exceeded.
［実施例１〜１８及び比較例１〜１０］
表１及び表２に示す処方のロールオンを常法に従って製造し、油剤の安定配合、耐水残留性、耐擦れ性、耐よれ性、塗布後の肌のべたつき及び塗布後の肌の滑らかさをそれぞれ評価した。以下に各評価方法の詳細を示し、全ての結果を表１及び表２に示す。なお、特記のない限り、配合量の％は全て質量％を表す。
[Examples 1 to 18 and Comparative Examples 1 to 10]
The roll-ons of the formulations shown in Tables 1 and 2 are manufactured according to a conventional method, and stable blending of oils, water persistence, rubbing resistance, twist resistance, stickiness of the skin after application and smoothness of the skin after application are obtained, respectively. evaluated. The details of each evaluation method are shown below, and all the results are shown in Tables 1 and 2. Unless otherwise specified, all% of the blending amount represents mass%.
＜油剤の安定配合＞
各実施例及び比較例において全ての成分を混合した後に、油剤が安定して配合されているか否かを目視で評価した。安定して配合されている場合は◎、経時で分離した場合は△、最初から分離している、又は配合が不可能である場合は×とした。
<Stable formulation of oil>
After mixing all the components in each Example and Comparative Example, it was visually evaluated whether or not the oil agent was stably blended. When it was stably blended, it was marked with ⊚, when it was separated over time, it was marked with Δ, and when it was separated from the beginning or it was impossible to blend, it was marked with ×.
＜耐水残留性＞
人工皮革(６×６ｃｍ)に試験品を０．５ｇ塗布し、室温で１時間静置し乾燥させた。この人工皮革を精製水１００ｍｌに５分浸漬した後、人工皮革に残存したデオドラント成分の定量分析を行った。被膜成分が含まれていない時の水洗い試験後の残存デオドラント成分量は６５％であったが、それと比較して水洗後の残存デオドラント成分量が２０％以上向上した場合は◎、水洗後の残存デオドラント成分量が１０％以上向上した場合は○、水洗後の残存デオドラント成分量が５％以上向上した場合は△、水洗後の残存デオドラント成分量に変化がない場合は×とした。
<Water resistance>
0.5 g of the test product was applied to artificial leather (6 x 6 cm), and the mixture was allowed to stand at room temperature for 1 hour to dry. After immersing this artificial leather in 100 ml of purified water for 5 minutes, a quantitative analysis of the deodorant component remaining in the artificial leather was performed. The amount of residual deodorant component after the washing test was 65% when the film component was not contained, but when the amount of residual deodorant component after washing with water improved by 20% or more, ◎, the amount of residual deodorant component after washing with water When the amount of deodorant component was improved by 10% or more, it was evaluated as ◯, when the amount of residual deodorant component after washing with water was improved by 5% or more, it was evaluated as Δ, and when the amount of residual deodorant component after washing with water was not changed, it was evaluated as x.
＜耐擦れ性＞
人工皮革に試験品を均一に塗布(３ｃｍ×３ｃｍ、０．１ｇ）し、室温にて１時間静置し乾燥させた。その後、ブラシを用いて同方向に１０回ブラッシングし、下記式に従い残存率を算出した。被膜成分が含まれていない時の耐擦れ性試験後の残存率は５５％であったが、それと比較して残存率が２０％以上向上した場合は◎、残存率が１０％以上向上した場合は○、残存率が５％以上向上した場合は△、残存率に変化がない場合は×とした。
残存率（％）＝（ブラッシング後の試験品重量（ｇ）／乾燥後の試験品重量（ｇ）×１００）
<Scratch resistance>
The test product was uniformly applied to the artificial leather (3 cm × 3 cm, 0.1 g), and allowed to stand at room temperature for 1 hour to dry. Then, it was brushed 10 times in the same direction with a brush, and the residual ratio was calculated according to the following formula. The residual rate after the rubbing resistance test when the film component was not contained was 55%, but when the residual rate was improved by 20% or more, it was ◎, and when the residual rate was improved by 10% or more. Was evaluated as ◯, when the residual rate improved by 5% or more, it was evaluated as Δ, and when there was no change in the residual rate, it was evaluated as ×.
Residual rate (%) = (weight of test product after brushing (g) / weight of test product after drying (g) x 100)
＜耐よれ性＞
試験品を人工皮膚モデルに０．５ｇ塗布し、乾燥させた。その後、人工皮膚モデルを折り曲げ、その様子を目視で評価した。乾燥後に均一な被膜を形成し、折り曲げ後によれが見られない場合は◎、乾燥後に均一な被膜を形成し、折り曲げ後によれがわずかに見られる場合は○、乾燥後に均一な被膜を形成するが、折り曲げ後に被膜が破壊される場合は△、乾燥後に均一な被膜を形成しない場合は×とした。
<Twist resistance>
0.5 g of the test product was applied to the artificial skin model and dried. Then, the artificial skin model was bent and the state was visually evaluated. If a uniform film is formed after drying and no wobbling is seen after bending, a uniform film is formed after drying, and if a slight wrinkle is seen after bending, a uniform film is formed after drying. , Δ if the film was broken after bending, and × if the film was not formed uniformly after drying.
＜塗布後の肌のべたつき＞
試験品を万遍なく肌に塗布し、２分後の肌のべたつきを触感で評価した。べたつきがない場合は◎、べたつきが少ない場合は○、べたつきがある場合は△、べたつきがあり、不快に感じる場合は×とした。
<Skin stickiness after application>
The test product was evenly applied to the skin, and the stickiness of the skin after 2 minutes was evaluated by touch. If there is no stickiness, it is marked with ◎, if it is less sticky, it is marked with ○, if it is sticky, it is marked with △, and if it is sticky and uncomfortable, it is marked with ×.
＜塗布後の肌の滑らかさ＞
試験品を万遍なく肌に塗布し、２分後の肌の滑らかさを触感で評価した。非常に滑らかである場合は◎、滑らかである場合は○、滑らかでない場合は×とした。
<Skin smoothness after application>
The test product was evenly applied to the skin, and the smoothness of the skin after 2 minutes was evaluated by touch. If it is very smooth, it is marked with ⊚, if it is smooth, it is marked with ○, and if it is not smooth, it is marked with ×.
表１に示すように、（Ａ）デオドラント成分と、（Ｂ）エタノールと、（Ｃ）フェニル変性シリコーンとを所定の数値範囲内で含有する実施例１〜１４のロールオンは、油剤の安定配合、耐水残留性、耐擦れ性、耐よれ性、塗布後の肌のべたつき及び塗布後の肌の滑らかさのいずれにおいても評価は良好であった。また、更に（Ｄ）脂肪酸エステルを含有する実施例１５〜１８のロールオンは、実施例１６及び１８において耐水残留性に少し劣るものの、他の油剤の安定配合、耐擦れ性、耐よれ性、塗布後の肌のべたつき及び塗布後の肌の滑らかさのいずれにおいても評価は良好であった。
それに対して、表２に示すように、（Ｃ）フェニル変性シリコーンを含まない比較例１及び２のロールオンは耐水残留性、耐擦れ性、耐よれ性及び塗布後の肌の滑らかさのいずれも不良であり、（Ｃ）フェニル変性シリコーンと（Ｄ）脂肪酸エステルを含むものの、合計が１４．００質量％である比較例３と、（Ｂ）エタノールが１．００質量％しか含まれていない比較例４は耐よれ性に劣るだけでなく、油剤の安定配合や耐擦れ性にも劣り、塗布後の肌のべたつきや滑らかさは大きく劣っていた。
As shown in Table 1, the roll-on of Examples 1 to 14 containing (A) deodorant component, (B) ethanol, and (C) phenyl-modified silicone within a predetermined numerical range is a stable blending of an oil agent. The evaluation was good in all of the water resistance, the rubbing resistance, the twist resistance, the stickiness of the skin after application, and the smoothness of the skin after application. Further, the roll-ons of Examples 15 to 18 further containing (D) fatty acid ester are slightly inferior in water resistance in Examples 16 and 18, but stable formulation, rubbing resistance, twist resistance, and coating of other oil agents. The evaluation was good in both the stickiness of the skin afterwards and the smoothness of the skin after application.
On the other hand, as shown in Table 2, the roll-ons of Comparative Examples 1 and 2 containing (C) phenyl-modified silicone did not have any of water persistence, rubbing resistance, twist resistance and smoothness of the skin after application. Comparative Example 3 which is defective and contains (C) phenyl-modified silicone and (D) fatty acid ester but has a total of 14.00% by mass, and (B) a comparison containing only 1.00% by mass of ethanol. Example 4 was not only inferior in twist resistance, but also inferior in stable blending and rubbing resistance of the oil agent, and the stickiness and smoothness of the skin after application were significantly inferior.
さらに、（Ａ）デオドラント成分の含有量と、（Ｃ）フェニル変性シリコーンの含有量との質量比が１５．００：０．２０＝７５：１である比較例５は油剤の安定配合、耐擦れ性及び耐よれ性のいずれも不良であり、塗布後の肌の滑らかさも大きく劣っていた。また、（Ｃ）フェニル変性シリコーンではなく通常のシリコーンを含む比較例６〜１０のいずれも耐水残留性、耐擦れ性、耐よれ性及び塗布後の肌の滑らかさのいずれも不良であった。
よって、本発明の皮膚外用組成物は、可動又は発汗の多い体の部位に塗布しても、よれに強く、フレキシブルな皮膜を形成することができる皮膚外用組成物、デオドラント剤及びロールオン製品を提供することができる。
Further, in Comparative Example 5 in which the mass ratio of (A) the content of the deodorant component and (C) the content of the phenyl-modified silicone is 15.00: 0.20 = 75: 1, stable blending of the oil agent and abrasion resistance Both the property and the kinking resistance were poor, and the smoothness of the skin after application was also significantly inferior. In addition, all of Comparative Examples 6 to 10 containing (C) ordinary silicone instead of phenyl-modified silicone were poor in water persistence, rubbing resistance, twist resistance, and smoothness of the skin after application.
Therefore, the external composition for skin of the present invention provides a composition for external skin, a deodorant, and a roll-on product that can form a flexible film that is resistant to twisting even when applied to a movable or sweaty body part. can do.
以上、実施形態及び実施例を用いて本発明を説明したが、本発明の技術的範囲は上記実施形態及び実施例に記載の範囲には限定されないことは言うまでもない。上記実施形態及び実施例に、多様な変更又は改良を加えることが可能であることが当業者に明らかである。またそのような変更又は改良を加えた形態も本発明の技術的範囲に含まれ得ることが、特許請求の範囲の記載から明らかである。 Although the present invention has been described above using the embodiments and examples, it goes without saying that the technical scope of the present invention is not limited to the scope described in the above embodiments and examples. It will be apparent to those skilled in the art that various changes or improvements can be made to the above embodiments and examples. Further, it is clear from the description of the scope of claims that the form to which such a modification or improvement is added may be included in the technical scope of the present invention.
Claims (9)
（Ｂ）エタノールと、
（Ｃ）フェニル変性シリコーンと
を含有することを特徴とする皮膚外用組成物。 (A) Deodorant component and
(B) Ethanol and
(C) A composition for external use on the skin, which comprises a phenyl-modified silicone.
（Ａ−２）グリチルレチン酸、イソプロピルメチルフェノール、塩化ベンザルコニウム、塩化ベンゼトニウム、ハロカルバン、塩化アルキルトリメチルアンモニウム、レゾルシン、塩酸クロルヘキシジン、フェノール、フェノキシエタノール、安息香酸誘導体、トリクロロヒドロキシジフェニルエーテル、トリクロロカルバニリド、トリエチルシトレート、ヘキサクロロフェン、グルコン酸クロルヘキシジン、トリクロサン、サリチル酸、ソルビン酸、塩化リゾチーム及びエチルヘキシルグリセリンから選ばれる殺菌成分と
（Ａ−３）銀担持ゼオライト、銀担持シリカ、緑茶エキス、クワエキス、ユーカリエキス、ローズマリーエキス等の植物由来成分、ジヒドロファルネソール、フェネチルアルコール等の抗菌性香料、前記アルミニウム塩を除く金属塩、金属酸化物、珪藻土、粘土鉱物及び活性炭から選ばれる消臭成分のうち、
前記（Ａ−２）及び前記（Ａ−３）から選ばれる１種又は２種以上を含むことを特徴とする請求項１又は２に記載の皮膚外用組成物。 The (A) deodorant component
(A-2) Glycyrrhetinic acid, isopropylmethylphenol, benzalkonium chloride, benzethonium chloride, halocarban, alkyltrimethylammonium chloride, resorcin, chlorhexidine hydrochloride, phenol, phenoxyethanol, benzoic acid derivative, trichlorohydroxydiphenyl ether, trichlorocarbanilide, Bactericidal components selected from triethylcitrate, hexachlorophene, chlorhexidine gluconate, triclosan, salicylic acid, sorbic acid, lysozyme chloride and ethylhexyl glycerin (A-3) silver-bearing zeolite, silver-bearing silica, green tea extract, quail extract, eucalyptus extract, Of the deodorant components selected from plant-derived components such as rosemary extract, antibacterial fragrances such as dihydrofarnesol and phenethyl alcohol, metal salts other than the aluminum salt, metal oxides, diatomaceous soil, clay minerals and activated charcoal.
The external composition for skin according to claim 1 or 2, which comprises one or more selected from the above (A-2) and (A-3).
前記（Ｃ）フェニル変性シリコーン単独又は前記（Ｃ）フェニル変性シリコーンと前記（Ｄ）脂肪酸エステルの合計が０．１質量％以上１３．０質量％以下含まれることを特徴とする請求項１〜３のいずれか１項に記載の皮膚外用組成物。 In addition, it contains (D) fatty acid ester,
Claims 1 to 3 characterized in that the (C) phenyl-modified silicone alone or the total of the (C) phenyl-modified silicone and the (D) fatty acid ester is contained in an amount of 0.1% by mass or more and 13.0% by mass or less. The composition for external use on the skin according to any one of the above.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019207618A JP2021080188A (en) | 2019-11-18 | 2019-11-18 | External composition for skin, deodorant agent and roll-on product |
| JP2023179504A JP2023174875A (en) | 2019-11-18 | 2023-10-18 | External composition for skin, deodorant agent and roll-on product |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019207618A JP2021080188A (en) | 2019-11-18 | 2019-11-18 | External composition for skin, deodorant agent and roll-on product |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023179504A Division JP2023174875A (en) | 2019-11-18 | 2023-10-18 | External composition for skin, deodorant agent and roll-on product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2021080188A true JP2021080188A (en) | 2021-05-27 |
Family
ID=75966131
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019207618A Pending JP2021080188A (en) | 2019-11-18 | 2019-11-18 | External composition for skin, deodorant agent and roll-on product |
| JP2023179504A Pending JP2023174875A (en) | 2019-11-18 | 2023-10-18 | External composition for skin, deodorant agent and roll-on product |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023179504A Pending JP2023174875A (en) | 2019-11-18 | 2023-10-18 | External composition for skin, deodorant agent and roll-on product |
Country Status (1)
| Country | Link |
|---|---|
| JP (2) | JP2021080188A (en) |
-
2019
- 2019-11-18 JP JP2019207618A patent/JP2021080188A/en active Pending
-
2023
- 2023-10-18 JP JP2023179504A patent/JP2023174875A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023174875A (en) | 2023-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4782137B2 (en) | Cooling composition for cosmetics | |
| JP2003081761A (en) | Emulsified composition | |
| JP6663734B2 (en) | Hairdressing composition | |
| JP2015117239A (en) | Antiperspirant composition | |
| JP2015093859A (en) | Cosmetic | |
| JP6530236B2 (en) | Skin cream | |
| KR102367688B1 (en) | Transparent hair cosmetic composition | |
| JP2018065799A (en) | Cosmetic | |
| JP2021080188A (en) | External composition for skin, deodorant agent and roll-on product | |
| JP2002370958A (en) | Liquid cosmetic material | |
| JP2005350357A (en) | Body smell-preventing cosmetic | |
| JP6186106B2 (en) | Long lasting cosmetics | |
| JP2002370941A (en) | Hair cosmetic | |
| JP7009088B2 (en) | Antiperspirant composition | |
| JP6900121B2 (en) | Antiperspirant composition and antiperspirant | |
| JP2017122059A (en) | Body odor suppressing agent | |
| JP5296521B2 (en) | Hair treatment composition | |
| JP5296500B2 (en) | Hair conditioning composition | |
| JP2010059118A (en) | Hair dressing agent | |
| BR112021004113A2 (en) | antiperspirant compositions, method to minimize stains or yellowing and use | |
| JP3675637B2 (en) | Composition for external use | |
| JP3649619B2 (en) | Composition for external use | |
| JP7049868B2 (en) | Antiperspirant composition | |
| JP7355493B2 (en) | Skin cleansing composition | |
| RU2774862C1 (en) | Antiperspirant composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220930 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230809 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230822 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20240305 |